Updates on Dengue Vaccine and Antiviral: Where Are We Heading?
Approximately 100–400 million people from more than 100 countries in the tropical and subtropical world are affected by dengue infections. Recent scientific breakthroughs have brought new insights into novel strategies for the production of dengue antivirals and vaccines. The search for specific den...
Guardado en:
Autores principales: | Harun Norshidah, Ramachandran Vignesh, Ngit Shin Lai |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/dc66ccf0fba94e56aa7bec795ec99b09 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Diterpenes/Diterpenoids and Their Derivatives as Potential Bioactive Leads against Dengue Virus: A Computational and Network Pharmacology Study
por: Rasel Ahmed Khan, et al.
Publicado: (2021) -
Occurrence of Dengue Virus Infection with Multiple Serotypes at Central Karnataka, India
por: VinodKumar CS, et al.
Publicado: (2021) -
A Critical Role for Perivascular Cells in Amplifying Vascular Leakage Induced by Dengue Virus Nonstructural Protein 1
por: Yin P. Cheung, et al.
Publicado: (2020) -
NS1-based ELISA test efficiently detects dengue infections without cross-reactivity with Zika virus
por: Samuel Santos Pereira, et al.
Publicado: (2021) -
Efficient Control of Zika Virus Infection Induced by a Non-Replicating Adenovector Encoding Zika Virus NS1/NS2 Antigens Fused to the MHC Class II-Associated Invariant Chain
por: Loulieta Nazerai, et al.
Publicado: (2021)